< Terug naar vorige pagina
Publicatie
Comparative performance of genomic methods for the detection of pyrazinamide resistance and heteroresistance in Mycobacterium tuberculosis
Tijdschriftbijdrage - e-publicatie
Pyrazinamide is an important component of both drug-susceptible and drug-resistant tuberculosis treatment regimens. Although approximately 50% of rifampin-resistant isolates are also resistant to pyrazinamide, pyrazinamide susceptibility testing is not routinely performed due to the challenging nature of the assay.
Tijdschrift: Journal of clinical microbiology
ISSN: 0095-1137
Volume: 60
Jaar van publicatie:2022
Trefwoorden:A1 Journal article
Toegankelijkheid:Open